Receptor Occupancy Fails to Predict Immune Activation in Pembrolizumab Dosing Study
A translational modelling study finds that PD-1 receptor occupancy does not predict immune activation during pembrolizumab therapy, challenging current dosing ...
Tag: PD-1 inhibitors
Triple-Drug Antibody-Drug Conjugate Strategy Shows Promise in Hard-to-Treat Breast Cancer
A real-world study of 87 patients suggests that combining Trop-2 antibody-drug conjugates with PD-1 inhibitors and anti-angiogenic therapy substantially improves ...
SPARK Trial: New Treatment for Triple-Negative Breast Cancer
In the evolving landscape of cancer treatment, a pivotal study uncovers promising results involving the combination of Sitravatinib and Tislelizumab ...
PD-1 Inhibitors Enhance Outcomes After CD19 CAR-T
In the ever-evolving landscape of oncology, the search for effective therapeutic strategies against relapsed and refractory non-Hodgkin lymphoma (NHL) remains ...
Tyrosine Kinase and PD-1 Inhibitors Boost Liver Cancer Treatment
In a groundbreaking study poised to reshape therapeutic strategies for hepatocellular carcinoma (HCC), researchers have demonstrated the superior efficacy and ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!